BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37481826)

  • 1. Liver factor B silencing to cure C3 glomerulopathy: Evidence from a mouse model of complement dysregulation.
    Zanchi C; Locatelli M; Corna D; Cerullo D; Fishilevich E; Desai D; Rottoli D; Donadelli R; Noris M; Zoja C; Remuzzi G; Benigni A
    Mol Immunol; 2023 Sep; 161():25-32. PubMed ID: 37481826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Small Interfering RNA Targeting Complement C3 in a Mouse Model of C3 Glomerulopathy.
    Zanchi C; Locatelli M; Cerullo D; Aumiller V; Corna D; Rottoli D; Eisermann M; Donadelli R; Mousavi M; Noris M; Remuzzi G; Benigni A; Zoja C
    J Immunol; 2022 Apr; 208(7):1772-1781. PubMed ID: 35277417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy.
    Zanchi C; Locatelli M; Cerullo D; Aumiller V; Corna D; Rottoli D; Schubert S; Noris M; Tomasoni S; Remuzzi G; Zoja C; Benigni A
    Mol Immunol; 2024 Apr; 168():10-16. PubMed ID: 38368725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humanized C3 Mouse: A Novel Accelerated Model of C3 Glomerulopathy.
    Devalaraja-Narashimha K; Meagher K; Luo Y; Huang C; Kaplan T; Muthuswamy A; Halasz G; Casanova S; O'Brien J; Peyser Boiarsky R; McWhirter J; Gartner H; Bai Y; MacDonnell S; Liu C; Hu Y; Latuszek A; Wei Y; Prasad S; Huang T; Yancopoulos G; Murphy A; Olson W; Zambrowicz B; Macdonald L; Morton LG
    J Am Soc Nephrol; 2021 Jan; 32(1):99-114. PubMed ID: 33288630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.
    Yang Y; Denton H; Davies OR; Smith-Jackson K; Kerr H; Herbert AP; Barlow PN; Pickering MC; Marchbank KJ
    J Am Soc Nephrol; 2018 Jun; 29(6):1649-1661. PubMed ID: 29588430
    [No Abstract]   [Full Text] [Related]  

  • 6. C3(H2O) prevents rescue of complement-mediated C3 glomerulopathy in Cfh-/- Cfd-/- mice.
    Zhang Y; Keenan A; Dai DF; May KS; Anderson EE; Lindorfer MA; Henrich JB; Pitcher GR; Taylor RP; Smith RJ
    JCI Insight; 2020 May; 5(9):. PubMed ID: 32376801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.
    Noris M; Donadelli R; Remuzzi G
    Pediatr Nephrol; 2019 Aug; 34(8):1311-1323. PubMed ID: 29948306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
    Servais A; Noël LH; Roumenina LT; Le Quintrec M; Ngo S; Dragon-Durey MA; Macher MA; Zuber J; Karras A; Provot F; Moulin B; Grünfeld JP; Niaudet P; Lesavre P; Frémeaux-Bacchi V
    Kidney Int; 2012 Aug; 82(4):454-64. PubMed ID: 22456601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dense deposit disease and C3 glomerulopathy.
    Barbour TD; Pickering MC; Terence Cook H
    Semin Nephrol; 2013 Nov; 33(6):493-507. PubMed ID: 24161036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.
    Donadelli R; Pulieri P; Piras R; Iatropoulos P; Valoti E; Benigni A; Remuzzi G; Noris M
    Front Immunol; 2018; 9():2329. PubMed ID: 30487789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy.
    Vernon KA; Ruseva MM; Cook HT; Botto M; Malik TH; Pickering MC
    J Am Soc Nephrol; 2016 May; 27(5):1334-42. PubMed ID: 26374608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3 Glomerulopathy.
    Riedl M; Thorner P; Licht C
    Pediatr Nephrol; 2017 Jan; 32(1):43-57. PubMed ID: 27056062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of Fatal C3 Glomerulopathy by Recombinant Complement Receptor of the Ig Superfamily.
    Wang X; Van Lookeren Campagne M; Katschke KJ; Gullipalli D; Miwa T; Ueda Y; Wang Y; Palmer M; Xing G; Song WC
    J Am Soc Nephrol; 2018 Aug; 29(8):2053-2059. PubMed ID: 29895552
    [No Abstract]   [Full Text] [Related]  

  • 14.
    Piras R; Breno M; Valoti E; Alberti M; Iatropoulos P; Mele C; Bresin E; Donadelli R; Cuccarolo P; Smith RJH; Benigni A; Remuzzi G; Noris M
    Front Genet; 2021; 12():670727. PubMed ID: 34211499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand factor variants in C3 glomerulopathy: A Chinese cohort study.
    Chen YY; Han SS; Cao Y; Yu XJ; Zhu L; Luo JC; Song WC; Yu F; Mao YH; Zhao MH
    Clin Immunol; 2021 Aug; 229():108794. PubMed ID: 34245915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome.
    Iatropoulos P; Noris M; Mele C; Piras R; Valoti E; Bresin E; Curreri M; Mondo E; Zito A; Gamba S; Bettoni S; Murer L; Fremeaux-Bacchi V; Vivarelli M; Emma F; Daina E; Remuzzi G
    Mol Immunol; 2016 Mar; 71():131-142. PubMed ID: 26895476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
    Osborne AJ; Breno M; Borsa NG; Bu F; Frémeaux-Bacchi V; Gale DP; van den Heuvel LP; Kavanagh D; Noris M; Pinto S; Rallapalli PM; Remuzzi G; Rodríguez de Cordoba S; Ruiz A; Smith RJH; Vieira-Martins P; Volokhina E; Wilson V; Goodship THJ; Perkins SJ
    J Immunol; 2018 Apr; 200(7):2464-2478. PubMed ID: 29500241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis.
    Lesher AM; Zhou L; Kimura Y; Sato S; Gullipalli D; Herbert AP; Barlow PN; Eberhardt HU; Skerka C; Zipfel PF; Hamano T; Miwa T; Tung KS; Song WC
    J Am Soc Nephrol; 2013 Jan; 24(1):53-65. PubMed ID: 23204401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in complement alternative pathway components, factor B and factor H during dengue virus infection in the AG129 mouse.
    Cabezas-Falcon S; Norbury AJ; Hulme-Jones J; Klebe S; Adamson P; Rudd PA; Mahalingam S; Ong LC; Alonso S; Gordon DL; Carr JM
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33410734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the complement biomarker profile of C3 glomerulopathy.
    Zhang Y; Nester CM; Martin B; Skjoedt MO; Meyer NC; Shao D; Borsa N; Palarasah Y; Smith RJ
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1876-82. PubMed ID: 25341722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.